Aravive Biologics aravive.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Aravive Biologics is a pharmaceutical company dedicated to translating fundamental biological insights into new therapies that address major unmet clinical needs. Its approach is to target critical survival pathways both for hematologic malignancies as well as advanced solid tumors. The company's primary therapeutic focus is the GAS6-AXL pathway, where AXL receptor signaling plays a critical role in multiple types of malignancies by promoting metastasis and cancer cell survival.

Aravive Biologics is a pharmaceutical company dedicated to translating fundamental biological insights into new therapies that address major unmet clinical needs. Its approach is to target critical survival pathways both for hematologic malignancies ...Show all

Company (IPO / Went public)

Phone: 936-355-1910

Fax:

LyondellBasell Tower, Ste. 3200
1221 McKinney Street
Houston, 77010
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Aravive Biologics $0.4M Oct 15, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Aravive Biologics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Astellas Venture ManagementCorporate VentureMenlo Park, California, United StatesOther Investors
3E BioventuresVenture CapitalBeijing, Beijing, ChinaSeed VC
Sky Kingdom CapitalVenture CapitalSeed VC
See all 3 investors
There is no Competitors data available for this company. Please select another tab.